Pfizer to acquire obesity drug firm Metsera in $4.9B dealSeptember 23, 2025 Pfizer will acquire biotech Metsera for $4.9B in cash, expanding its obesity treatment portfolio with milestone payments possibly raising the deal to $7.3B.
